Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714451 · ClinicalTrials.gov registry record · NA
Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03714451 is a NA study that has completed, run by Yale University. The registered enrollment target is 24 participants.
The verdict
NCT03714451, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
Interventions
- DIETARY_SUPPLEMENT onyx sorghum
- DIETARY_SUPPLEMENT whole wheat flour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714451
The ClinicalTrials.gov registry entry for NCT03714451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which onyx sorghum is the first listed.
NCT03714451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03714451 about?
NCT03714451 is a clinical study titled "Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes". To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
What is the current status of trial NCT03714451?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-11-01. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT03714451?
The interventions under investigation include: onyx sorghum (DIETARY_SUPPLEMENT), whole wheat flour (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03714451?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.